Subgroup analysis of leiomyosarcoma patients from a phase 3, open-label, randomized study of eribulin versus dacarbazine in patients with advanced liposarcoma or leiomyosarcoma
EUROPEAN JOURNAL OF CANCER（2017）
关键词
leiomyosarcoma patients,advanced liposarcoma,dacarbazine,eribulin,open-label
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要